Latest Post

Treatment rationing, other structural barriers stand in the way of stopping spread of hepatitis C among people living with HIV, study finds

When provinces in Canada lifted restrictions pegging eligibility for treatment for hepatitis C with direct-acting antivirals to the stage of the disease — or range of liver damage — to make the medicines universally accessible, the numbers of people who accessed the treatment nearly doubled, a study reported in Clinical Infectious Diseases found. New initiation […]

More »

Recent Posts

Modern military era provides paths for growing global health threats

Haiti already faced a daunting path to recovery in the wake of the catastrophic 2010 earthquake that destroyed much of its capital city, with devastating damage to the nation’s health infrastructure, when UN peacekeeping forces came from Kathmandu came to provide support. Unknown to them, some had been infected with cholera in their previous posting, […]

More »

What we’re reading: Violating law and human rights, immigrant detention conditions, policies are also at odds with U.S. public health priorities

Denying flu shots to immigrants in custody a stark violation of law, ethics – In this Medpage Today opinion piece Dr. Cynthia Sears, the president of the Infectious Diseases Society of America (which produces this blog) and professor of medicine at the Johns Hopkins University School of Medicine, condemns the decision by U.S. Customs and […]

More »

New TB drug approval a milestone, all agree — with caveats, some add

The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against the deadliest and most resistant form of the disease represented a major step forward on multiple fronts, international treatment advocates agree. One of only three new drugs receiving regulatory […]

More »
More Recent Posts »

Live Blog Archive

CODEL Video

Click above for a video on our Congressional study tour to Africa, and click here to read more.

HIV

When viral suppression didn’t last, lowering barriers to HIV treatment and care made a difference

The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]

Tuberculosis

New TB drug approval a milestone, all agree — with caveats, some add

The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]

Research & Development

STREAM Trial: Nine-month regimen for drug-resistant tuberculosis brings “promising cure rates”

A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]

Policy

Treatment rationing, other structural barriers stand in the way of stopping spread of hepatitis C among people living with HIV, study finds

When provinces in Canada lifted restrictions pegging eligibility for treatment for hepatitis C with direct-acting antivirals to the stage of the disease — or range of […]